Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00177489
Other study ID # AG13305
Secondary ID
Status Completed
Phase N/A
First received September 12, 2005
Last updated January 4, 2016
Start date June 2002
Est. completion date September 2005

Study information

Verified date January 2016
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The primary goal of this study is to test a single multi-component intervention among family caregivers of persons with Alzheimer's disease or related disorders. The overall objectives of study are to 1) identify and reduce modifiable risk factors among diverse family caregivers of patients with Alzheimer's Disease or a related disorder, 2) enhance the quality of care of the care recipients, and 3) enhance the well-being of the caregivers.


Description:

The proposed Coordinating Center (CC) will work with five sites and staff from the National Institute on Aging (NIA) and the National Institute of Nursing Research (NINR) to implement a multi-site caregiver intervention trial. The overall objective of this research program is to refine and test a multicomponent psychosocial intervention to reduce burden and depression among family caregivers of persons with Alzheimer's Disease or a related disorder. This competing renewal will build upon results obtained from its parent multi-site feasibility study, Resources for Enhancing Alzheimer's Caregiver Health (REACH) funded by the NIA/NINR as a cooperative agreement (UO1-AG13305). In the study proposed here, five intervention sites (Birmingham, Memphis, Miami, Palo Alto, and Philadelphia) will recruit 600 (120 per site) caregiver-care recipient dyads consisting of equal numbers of African Americans/Blacks, Hispanics/Latinos, and Caucasians/Whites. Caregivers will be randomized to either an in-home multicomponent intervention condition or a standardized information-only control condition.

The Coordinating Center at the University of Pittsburgh will work with the intervention site investigators and the NIA/NINR to support the implementation of the intervention study at each site and to collect and analyze a common database across sites.


Recruitment information / eligibility

Status Completed
Enrollment 613
Est. completion date September 2005
Est. primary completion date September 2005
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Caregiver Inclusion/Exclusion Criteria:

- Inclusion Criteria:

1. Age: 21 years or older

2. Family member of the care recipient

3. Must live with care recipient or share cooking facilities

4. Must have a telephone that will enable use of CTIS (Computer Telephone Integration System) system

5. Must plan to remain in the recruitment area for the duration of the intervention and follow-up

6. Caregiver role for more than 6 months

7. Must provide on average 4 hours of supervision or direct assistance per day for the care recipient

8. Risk Screening Tool: must have a total score of at least 1 for questions 1-3, and a total of at least 2 for questions 4-9

Exclusion Criteria:

1. Non-English, non-Spanish speaking

2. Active treatment (chemotherapy, radiation therapy) for cancer

3. Imminent placement of care recipient into a nursing home or with another caregiver (within 6 months)

4. Involvement in another clinical trial for caregivers

5. Participant in REACH I study

6. SPMSQ:> or = 4 errors*

- If the caregiver has been inconsistent with answers or repeated answers during the screening process, then the interviewer administers the Short Portable Mental Status Questionnaire (SPMSQ). If the caregiver missed 4 or more questions, he/she was excluded from the study.

Care Recipient Inclusion/Exclusion Criteria

Inclusion Criteria:

a. NINCDS (MD diagnosis) of dementia or cognitive impairment (raw score on MMSE of 23 or less)

Exclusion Criteria:

1. Non-English, non-Spanish speaking

2. History of Parkinson's Disease or a stroke with no reported decline in memory over the past year

3. Active treatment (chemotherapy, radiation therapy) for cancer

4. More than three acute medical hospitalizations in past year (other than psychiatric or Alzheimer's Disease related admission)

5. Schizophrenia (onset of delusions before age 45) or other severe mental illness

6. Dementia secondary to head trauma (probable)

7. Blindness or deafness if either disability prohibits them from completion of data collection or participation in the interventions

8. MMSE = 0 and Bedbound (confined to a bed or chair for >22 hours per day, for at least 4 of the past 7 days)

9. Planned nursing home admission in 6 months

10. Participant in REACH I study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
multicomponent psychosocial intervention
The intervention addressed caregiver depression, burden, self-care, and social support and care recipient problem behaviors through 12 in-home and telephone sessions over 6 months.
Other:
Control arm
Caregivers in the control group received 2 brief "check-in" telephone calls during the 6-month intervention.

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama
United States University of Tennessee Health Science Center Memphis Tennessee
United States Stanford University and Veterans Affairs Menlo Park California
United States University of Miami at Miami, Center on Adult Development and Aging Miami Florida
United States Thomas Jefferson University at Philadelphia, Center for Applied Research on Aging and Health Philadelphia Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
University of Pittsburgh National Institute of Nursing Research (NINR), National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher-Thompson D, Gitlin LN, Klinger J, Koepke KM, Lee CC, Martindale-Adams J, Nichols L, Schulz R, Stahl S, Stevens A, Winter L, Zhang S; Resources for Enhancing Alzheimer's Caregiver Health (REACH) II I — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary multivariate quality of life indicator- assessed caregiver burden, depressive symptoms, self-care, social support and patient problem behaviors. Assessed at six months post-randomization. six months No
Secondary Caregiver clinical depression and patient institutional placement-six months post-randomization. six months No
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A